| 2D Structure | |
| CID | 15376 |
| IUPAC Name | methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate |
| InChI | InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1 |
| InChI Key | RXPRRQLKFXBCSJ-GIVPXCGWSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C21H26N2O3 |
| Molecular Weight | 354.4 |
| synonyms | ['vincamine', '1617-90-9', 'Pervincamine', 'Arteriovinca', 'Angiopac', 'Vincafor', 'Vincamidol', 'Novicet', 'Methyl vincaminate', 'Oxygeron', 'Vincagil', 'Equipur', 'Vincafolina', 'Tripervan', 'Vincadar', 'Ocu-vinc', 'Vincamina', 'Vincimax', 'Perval', 'Pervone', 'Vincaminum', 'Vraap', 'Vinodrel retard', 'DTXSID9040134', 'Cetal retard', '996XVD0JHT', 'Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16alpha)-', 'NSC-91998', 'CHEBI:9985', 'DTXCID7020134', 'methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate', 'methyl 14beta-hydroxy-14,15-dihydro-3alpha,16alpha-eburnamenine-14alpha-carboxylate', 'methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo(9.6.2.0^(2,7).0^(8,18).0^(15,19))nonadeca-2,4,6,8(18)-tetraene-17-carboxylate', 'methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo(9.6.2.02,7.08,18.015,19)nonadeca-2,4,6,8(18)-tetraene-17-carboxylate', 'methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate', 'RefChem:194264', 'C04AX07', '216-576-3', 'Devincan', 'Minorine', '(+)-Vincamine', 'Vincamin', 'Anasclerol', 'Monorin', 'Devinkan', 'Vincasaunier', 'Decincan', 'Vincapront', 'Vinkametrin', 'Minorin', 'MFCD00078054', 'Vincachron', 'Vincapan', 'Vinca-Ecobi', 'Vinca-Minor', 'Alkaloid obtained from Vinca minor', 'Anasclerol (base)', '14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester', 'Vincamine (INN)', 'Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methylester, (3a,14b,16a)-', 'VINCAMINE [INN]', 'Methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate', 'Vincamina [DCIT]', 'Vincamine base', 'Vincaminum [INN-Latin]', 'Vincamine [INN:BAN:DCF]', 'HSDB 7150', 'EINECS 216-576-3', 'NSC 91998', 'UNII-996XVD0JHT', 'Pervincamine;', 'Vincamarine;', 'Minorine;', 'Vincamine CRS', 'NCGC00094824-01', 'Prestwick_495', 'CAS-1617-90-9', 'Vincamine for system suitability CRS', 'Cetal retard (TN)', 'Vincamine, 98%', 'Vincamine (Standard)', 'VINCAMINE [MI]', 'VINCAMINE [HSDB]', 'Prestwick0_000271', 'Prestwick1_000271', 'Prestwick2_000271', 'Prestwick3_000271', 'VINCAMINE [MART.]', 'VINCAMINE [WHO-DD]', 'Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16.)', 'BSPBio_000142', 'GTPL349', 'MLS002154249', 'SCHEMBL147179', 'SPBio_002361', 'BPBio1_000158', 'CHEMBL1165342', 'SCHEMBL29710919', 'VINCAMINE [EP MONOGRAPH]', 'BCBcMAP01_000080', 'HY-B1021R', 'HMS1568H04', 'HMS2095H04', 'HMS2268C20', 'HMS3712H04', 'HY-B1021', 'Tox21_111342', 'Tox21_301968', 's3891', 'AKOS015896471', 'Tox21_111342_1', 'CCG-208544', 'CS-4536', 'DB13374', 'EBC-618387', 'FV65205', 'KS-5179', 'SMP1_000314', 'Vincamine, analytical reference material', 'NCGC00184983-01', 'NCGC00184983-03', 'NCGC00255542-01', 'AC-22625', 'SMR000112509', 'SY057985', 'NS00006858', 'C09251', 'D08677', 'F463487', 'Q416225', 'BRD-K40902647-001-03-7', 'Vincamine Working Standard (Secondary Reference Standard)', 'Methyl 14beta-hydroxy-3alpha,16alpha-14,15-dihydroeburnamenine-14alpha-carboxylate', '(3alpha,14beta,16alpha)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester', '(4(1)S,12S,13aS)-methyl 13a-ethyl-12-hydroxy-2,3,4(1),5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate', '(41S,12S,13aS)-methyl 13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate', 'Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-,methyl ester, (3alpha,14beta,16alpha)-', 'methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0?,?.0?,??.0??,??]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate', 'methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18)-tetraene-17-carboxylate', 'methyl(15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate', 'Methyl(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate'] |
From Pubchem